Crown Wealth Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,700
| Closed | -$428K | – | 73 |
|
|
2023
Q2 | $428K | Sell |
4,700
-700
| -13% | -$63.8K | 0.34% | 37 |
|
|
2023
Q1 | $356K | Sell |
5,400
-6,414
| -54% | -$423K | 0.3% | 43 |
|
|
2022
Q4 | $611K | Buy |
11,814
+6,840
| +138% | +$354K | 0.57% | 28 |
|
|
2022
Q3 | $340K | Buy |
+4,974
| New | +$340K | 0.35% | 39 |
|
|
2022
Q1 | – | Sell |
-5,040
| Closed | -$238K | – | 98 |
|
|
2021
Q4 | $238K | Buy |
+5,040
| New | +$238K | 0.22% | 64 |
|